Please Wait
Applying Filters...
menu
    • menu
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Haemophilus Influenzae Type B

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3SANOFI PASTEUR LIMITED

    02 2ASTRAZENECA CANADA INC

    03 1GLAXOSMITHKLINE INC

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    SANOFI PASTEUR LIMITED

    France
    arrow
    The Pharmacy Technology
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    HAEMOPHILUS INFLUENZAE TYPE B-PRP

    Brand Name : ACT-HIB

    Dosage Form : KIT

    Dosage Strength : 10MCG/0.5ML

    Packaging : 5X1VIAL - 5X0.5ML AMP

    Approval Date :

    Application Number : 1959034

    Regulatory Info : Schedule D

    Registration Country : Canada

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    SANOFI PASTEUR LIMITED

    France
    arrow
    The Pharmacy Technology
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    HAEMOPHILUS INFLUENZAE TYPE B-PRP

    Brand Name : PEDIACEL

    Dosage Form : SUSPENSION

    Dosage Strength : 10MCG/0.5ML

    Packaging : 5X0.5ML

    Approval Date :

    Application Number : 2243167

    Regulatory Info : Schedule D

    Registration Country : Canada

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    SANOFI PASTEUR LIMITED

    France
    arrow
    The Pharmacy Technology
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    HAEMOPHILUS INFLUENZAE TYPE B-PRP

    Brand Name : PENTACEL

    Dosage Form : SUSPENSION

    Dosage Strength : 10MCG/0.5ML

    Packaging :

    Approval Date :

    Application Number : 2534797

    Regulatory Info : Schedule D

    Registration Country : Canada

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    ASTRAZENECA CANADA INC

    United Kingdom
    The Pharmacy Technology
    Not Confirmed
    arrow

    ASTRAZENECA CANADA INC

    United Kingdom
    arrow
    The Pharmacy Technology
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    INFLUENZA VIRUS TYPE B (VICTORIA)

    Brand Name : FLUMIST QUADRIVALENT

    Dosage Form : SPRAY

    Dosage Strength : 32000000FFU/0.2ML

    Packaging :

    Approval Date :

    Application Number : 2426544

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    ASTRAZENECA CANADA INC

    United Kingdom
    The Pharmacy Technology
    Not Confirmed
    arrow

    ASTRAZENECA CANADA INC

    United Kingdom
    arrow
    The Pharmacy Technology
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    INFLUENZA VIRUS TYPE B (YAMAGATA)

    Brand Name : FLUMIST QUADRIVALENT

    Dosage Form : SPRAY

    Dosage Strength : 32000000FFU/0.2ML

    Packaging :

    Approval Date :

    Application Number : 2426544

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    GLAXOSMITHKLINE INC

    United Kingdom
    The Pharmacy Technology
    Not Confirmed
    arrow

    GLAXOSMITHKLINE INC

    United Kingdom
    arrow
    The Pharmacy Technology
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    HAEMOPHILUS INFLUENZAE TYPE B-PRP

    Brand Name : INFANRIX HEXA

    Dosage Form : SUSPENSION

    Dosage Strength : 10MCG/0.5ML

    Packaging : 10X0.5ML

    Approval Date :

    Application Number : 2253852

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF